Boston Trust Walden Corp Sells 628 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Boston Trust Walden Corp cut its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 1.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 32,314 shares of the medical instruments supplier’s stock after selling 628 shares during the period. Boston Trust Walden Corp owned approximately 0.15% of Mettler-Toledo International worth $39,542,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. grew its holdings in shares of Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after buying an additional 17 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in shares of Mettler-Toledo International during the 3rd quarter worth approximately $37,000. Sound Income Strategies LLC raised its holdings in shares of Mettler-Toledo International by 4,500.0% in the fourth quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock valued at $56,000 after purchasing an additional 45 shares during the last quarter. Raleigh Capital Management Inc. lifted its position in shares of Mettler-Toledo International by 272.7% in the third quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 30 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its holdings in Mettler-Toledo International by 60.0% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 18 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on MTD shares. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. Stifel Nicolaus reduced their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Robert W. Baird lowered their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Wells Fargo & Company cut their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Finally, Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their target price for the stock from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. One analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $1,351.25.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. The trade was a 95.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,343.97 on Tuesday. The firm’s fifty day moving average price is $1,267.00 and its two-hundred day moving average price is $1,343.14. The company has a market cap of $28.36 billion, a P/E ratio of 36.24, a P/E/G ratio of 4.83 and a beta of 1.13. Mettler-Toledo International Inc. has a one year low of $1,133.46 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. As a group, equities research analysts expect that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.